Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...

Semaglutide, the active ingredient behind blockbuster weight-loss drugs like Wegovy, is now at the center of a growing body of evidence suggesting it can sharply reduce alcohol consumption in people ...

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide ...

2/20/25 (LAPost.com) — New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption. The study, published in JAMA ...

By Nancy Lapid March 4 (Reuters) - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent new substance use ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

A new study has revealed another benefit of the diabetes medication turned weight loss drug Ozempic. Health experts now say it could also help those with alcohol-use disorder. A study published this ...

Among participants in the semaglutide treatment group, the likelihood of zero heavy drinking days increased significantly between weeks 1 through 4 and weeks 5 to 8. Glucagon-like peptide 1 receptor ...